Axonics Inc at Wells Fargo Healthcare Conference Transcript
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It is my pleasure to host this session with Axonics. With us, we have Ray Cohen, the CEO; and Dan Dearen, the President and CFO.
In terms of format, it's going to be a fireside chat. If anybody has a question, raise your hand and we will call on you. So Ray and Dan, thanks so much for being here.
Thank you. Appreciate the invite.
Questions & Answers
So Ray, let's start with the macro environment. On the Q2 call, you indicated that COVID deferrals and procedures slowed down and slowdowns and staffing shortages did not really impact your Q2 results. But you did note some supply chain challenges and higher costs for certain components, which you've been able to manage the impact of so far. So how do you see the macro environment right now? What's getting better, what's getting worse?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |